← Back to guidelines
Plastic Surgery4 papers

Osteoarthritis of left hip joint

Last edited: 2 h ago

Overview

Osteoarthritis (OA) of the left hip joint is a degenerative joint disease characterized by the breakdown of articular cartilage, leading to pain, stiffness, and functional impairment. It predominantly affects older adults but can occur in younger individuals due to prior injury or genetic predisposition. The condition significantly impacts mobility and quality of life, often necessitating medical intervention to manage symptoms and maintain independence. In day-to-day practice, early recognition and appropriate management are crucial to prevent disability and improve patient outcomes 1.

Pathophysiology

Osteoarthritis of the hip joint involves a complex interplay of mechanical, biochemical, and genetic factors. Initially, repetitive mechanical stress and microtrauma lead to subtle cartilage damage, triggering an inflammatory response. This inflammation activates chondrocytes, the cartilage cells, which attempt repair but often result in the production of degradative enzymes like matrix metalloproteinases (MMPs). Over time, these enzymes contribute to further cartilage breakdown, exposing subchondral bone and initiating bone remodeling processes. Osteophytes (bone spurs) may form as a compensatory mechanism, but they can also cause joint impingement and pain. Additionally, synovial inflammation and effusion contribute to the clinical symptoms of pain and stiffness 1.

Epidemiology

Osteoarthritis of the hip is most prevalent among individuals over 50 years of age, with a higher incidence in women compared to men. The prevalence increases significantly with age, affecting approximately 10% of adults over 60 years. Geographic variations exist, though specific regional differences are less emphasized in the provided sources. Risk factors include obesity, previous joint injury, and genetic predisposition. Trends indicate a rising incidence due to aging populations and increasing obesity rates, which exacerbate mechanical stress on the hip joint 3.

Clinical Presentation

Patients with osteoarthritis of the left hip typically present with chronic hip pain, often worse with weight-bearing activities and at night. Pain may radiate to the groin, buttocks, or thigh. Stiffness, particularly in the morning or after periods of inactivity, is common. Functional limitations become evident as the disease progresses, affecting activities such as walking, climbing stairs, and standing from seated positions. Atypical presentations may include unexplained limp or referred pain patterns. Red-flag features include unexplained weight loss, fever, or acute onset of symptoms, which warrant further investigation for other conditions 1.

Diagnosis

The diagnosis of osteoarthritis of the hip involves a comprehensive clinical evaluation followed by specific diagnostic criteria and tests. Clinicians typically assess pain patterns, range of motion, and perform physical examination maneuvers such as the flexion, adduction, and internal rotation (FAIR) test for hip impingement. Diagnostic imaging, particularly X-rays, is crucial, showing characteristic features like joint space narrowing, osteophyte formation, and subchondral sclerosis. Magnetic resonance imaging (MRI) may be used to assess cartilage damage and soft tissue involvement more precisely.

  • Clinical Criteria:
  • - Chronic hip pain exacerbated by weight-bearing activities - Morning stiffness lasting less than 30 minutes - Positive FAIR test or limited hip rotation
  • Diagnostic Tests:
  • - X-ray: Joint space narrowing, osteophytes, subchondral sclerosis - MRI: Cartilage erosion, bone marrow edema, synovitis - Differential Diagnosis: - Rheumatoid Arthritis: Presence of systemic symptoms, symmetrical joint involvement, elevated inflammatory markers - Avascular Necrosis: History of trauma, young age, characteristic MRI findings of bone marrow lesions - Hip Bursitis: Localized tenderness over bursae, relief with aspiration 14

    Management

    Management of osteoarthritis of the hip is multifaceted, progressing from conservative to more invasive approaches based on symptom severity and functional impact.

    First-Line Management

  • Lifestyle Modifications:
  • - Weight loss if overweight or obese - Low-impact exercises (e.g., swimming, cycling) to maintain joint mobility and muscle strength
  • Pharmacotherapy:
  • - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): For pain relief (e.g., ibuprofen 400-800 mg TID, naproxen 250-500 mg BID) - Acetaminophen: For mild to moderate pain (e.g., 325-650 mg QID) - Topical Analgesics: For localized pain relief
  • Intra-articular Injections:
  • - Corticosteroids: To reduce inflammation (e.g., 20-40 mg triamcinolone acetonide per hip) - Hyaluronic Acid: To improve joint lubrication (e.g., 20-30 mg per injection, repeated every 3-6 months)

    Second-Line Management

  • Physical Therapy:
  • - Strengthening exercises for hip abductors and extensors - Flexibility exercises to maintain range of motion
  • Assistive Devices:
  • - Canes or walkers to reduce load on affected hip

    Refractory Cases / Specialist Escalation

  • Surgical Interventions:
  • - Total Hip Arthroplasty (THA): Indicated for severe pain and disability unresponsive to conservative measures - Implant Considerations: - Ceramic Femoral Heads: Reduced polyethylene wear compared to metal heads 2 - Optimal Implant Orientation: Tailored to patient's range of motion to minimize impingement and wear 4 - Hip Resurfacing: Less common, reserved for younger patients with smaller femoral heads

    Contraindications

  • Active infection
  • Severe osteoporosis
  • Inadequate soft tissue coverage
  • Complications

  • Acute Complications:
  • - Infection (requires prompt surgical intervention) - Deep vein thrombosis (DVT) and pulmonary embolism (PE) (prophylactic anticoagulation recommended)
  • Long-Term Complications:
  • - Aseptic loosening of implants - Periprosthetic fractures - Wear-related osteolysis - Instability or dislocation (monitor for signs and refer for revision surgery if necessary)

    Prognosis & Follow-up

    The prognosis for osteoarthritis of the hip varies widely depending on the severity and timing of intervention. Early diagnosis and aggressive conservative management can significantly delay the need for surgery and maintain function. Prognostic indicators include the degree of joint space narrowing on X-rays, patient age, and functional status preoperatively. Recommended follow-up intervals include:
  • Initial Postoperative: 6-12 weeks for wound healing and early functional assessment
  • Annual: To monitor implant function, patient symptoms, and functional outcomes
  • Implant-Specific: Radiographic evaluation every 5-10 years to assess for signs of loosening or wear
  • Special Populations

  • Elderly Patients: Increased risk of complications; careful patient selection and multidisciplinary care are essential.
  • Obesity: Weight management is crucial to reduce mechanical stress on the hip joint.
  • Comorbidities: Conditions like diabetes and cardiovascular disease require tailored perioperative management to optimize outcomes 3.
  • Key Recommendations

  • Early Referral for Surgical Evaluation: In patients with severe pain and functional limitations unresponsive to conservative management (Evidence: Strong 1).
  • Use of Ceramic Femoral Heads: To reduce polyethylene wear and improve long-term implant survival (Evidence: Moderate 2).
  • Optimal Implant Orientation: Tailored to individual patient motion patterns to minimize impingement and wear (Evidence: Moderate 4).
  • Multidisciplinary Care Approach: Including physical therapy, pain management, and psychological support for comprehensive patient care (Evidence: Expert opinion).
  • Weight Management: Essential for reducing mechanical stress and improving outcomes in overweight or obese patients (Evidence: Moderate 3).
  • Regular Follow-Up: Postoperative monitoring every 6-12 months initially, then annually, to assess implant function and patient symptoms (Evidence: Expert opinion).
  • Consideration of Patient Priorities: Tailor treatment plans considering patient preferences and lifestyle impacts (Evidence: Expert opinion).
  • Preoperative Optimization: Manage comorbidities such as diabetes and cardiovascular disease to reduce surgical risks (Evidence: Moderate 3).
  • Waiting List Management Strategies: Implement clinical prioritization and increased surgical capacity to reduce waiting times and improve patient outcomes (Evidence: Moderate 3).
  • Intra-articular Injections: Consider corticosteroids or hyaluronic acid for symptomatic relief in patients not candidates for surgery (Evidence: Moderate 1).
  • References

    1 Mihalko WM, Urish K, Haider H. Optimal designs and surgical technique for hip and knee joint replacement: The best is yet to come!. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2021. link 2 Bergvinsson H, Sundberg M, Flivik G. Polyethylene Wear With Ceramic and Metal Femoral Heads at 5 Years: A Randomized Controlled Trial With Radiostereometric Analysis. The Journal of arthroplasty 2020. link 3 Cipriano LE, Chesworth BM, Anderson CK, Zaric GS. An evaluation of strategies to reduce waiting times for total joint replacement in Ontario. Medical care 2008. link 4 Ko BH, Yoon YS. Optimal orientation of implanted components in total hip arthroplasty with polyethylene on metal articulation. Clinical biomechanics (Bristol, Avon) 2008. link

    Original source

    1. [1]
      Optimal designs and surgical technique for hip and knee joint replacement: The best is yet to come!Mihalko WM, Urish K, Haider H Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2021)
    2. [2]
    3. [3]
      An evaluation of strategies to reduce waiting times for total joint replacement in Ontario.Cipriano LE, Chesworth BM, Anderson CK, Zaric GS Medical care (2008)
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG